Haleon (HLN) Cash & Current Investments (2021 - 2025)
Haleon (HLN) recorded quarterly Cash & Current Investments of $1.9 billion in Q4 2025, down 38.95% on a QoQ basis from $3.1 billion in Q4 2024, and down 38.95% year-over-year from $3.1 billion in Q4 2024.
Haleon (HLN) Cash & Current Investments (2021 - 2025) Analysis & Trends
Haleon has disclosed Cash & Current Investments across 5 years of filings, most recently posting $1.9 billion for Q4 2025.
- Quarterly Cash & Current Investments fell 38.95% year-over-year to $1.9 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.9 billion (down 38.95% YoY) and the FY2025 annual result came in at $1.8 billion, down 39.24% from the prior year.
- Cash & Current Investments retreated to $1.9 billion in Q4 2025, from $3.1 billion in the prior quarter.
- Over five years, Cash & Current Investments peaked at $3.1 billion in Q4 2024 and troughed at $381.7 million in Q2 2023.
- A 5-year average of $1.3 billion and a median of $1.3 billion in 2023 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2023 — Cash & Current Investments tumbled 79.52% — and 2024, when it surged 130.67%.
- Tracing HLN's Cash & Current Investments over 5 years: stood at $564.8 million in 2021, then surged by 52.43% to $860.9 million in 2022, then soared by 53.82% to $1.3 billion in 2023, then jumped by 130.67% to $3.1 billion in 2024, then slumped by 38.95% to $1.9 billion in 2025.
- Business Quant data shows HLN's Cash & Current Investments at $1.9 billion in Q4 2025, $3.1 billion in Q4 2024, and $541.5 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 2.15 Bn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 77.77 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.32 Bn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 511.86 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 498.58 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 750.88 Mn |
| 10 | Haleon | 1.09 Bn | -776.09 Mn | - | 1.86 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.86 Bn |
| Dec 31, 2024 | 3.05 Bn |
| Jun 30, 2024 | 541.49 Mn |
| Dec 31, 2023 | 1.32 Bn |
| Jun 30, 2023 | 381.67 Mn |
| Dec 31, 2022 | 860.93 Mn |
| Sep 20, 2022 | 1.64 Bn |
| Jun 30, 2022 | 1.86 Bn |
| Dec 31, 2021 | 564.82 Mn |